Squarepoint Ops LLC Protagonist Therapeutics, Inc Transaction History

Squarepoint Ops LLC

  • $59.6 Billion
  • Q2 2024

A detailed history of Squarepoint Ops LLC transactions in Protagonist Therapeutics, Inc stock. As of the latest transaction made, Squarepoint Ops LLC holds 9,823 shares of PTGX stock, worth $467,771. This represents 0.0% of its overall portfolio holdings.

Number of Shares
9,823
Holding current value
$467,771
% of portfolio
0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$24.66 - $34.8 $242,235 - $341,840
9,823 New
9,823 $340,000
Q4 2022

Feb 14, 2023
SELL
$7.36 - $11.17 $405,477 - $615,377
-55,092 Reduced 71.68%
21,770 $237,000
Q3 2022

Nov 14, 2022
BUY
$7.86 - $11.71 $174,381 - $259,798
22,186 Added 40.58%
76,862 $648,000
Q2 2022

Aug 15, 2022
BUY
$7.06 - $25.52 $288,513 - $1.04 Million
40,866 Added 295.92%
54,676 $432,000
Q1 2022

May 16, 2022
SELL
$23.34 - $36.08 $1.09 Million - $1.68 Million
-46,680 Reduced 77.17%
13,810 $327,000
Q4 2021

Feb 14, 2022
BUY
$17.63 - $37.1 $1.07 Million - $2.24 Million
60,490 New
60,490 $2.07 Million
Q1 2021

May 17, 2021
SELL
$19.02 - $31.15 $321,304 - $526,216
-16,893 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$18.49 - $25.13 $312,351 - $424,521
16,893 New
16,893 $341,000
Q3 2020

Nov 16, 2020
SELL
$15.19 - $22.4 $1.79 Million - $2.65 Million
-118,120 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$6.19 - $18.84 $501,619 - $1.53 Million
81,037 Added 218.53%
118,120 $3.41 Million
Q1 2020

May 15, 2020
SELL
$5.4 - $9.22 $302,508 - $516,504
-56,020 Reduced 60.17%
37,083 $262,000
Q4 2019

Feb 14, 2020
BUY
$4.69 - $13.45 $42,533 - $121,978
9,069 Added 10.79%
93,103 $656,000
Q3 2019

Nov 14, 2019
SELL
$9.41 - $16.56 $172,231 - $303,097
-18,303 Reduced 17.89%
84,034 $1.01 Million
Q2 2019

Aug 14, 2019
BUY
$8.98 - $12.96 $516,888 - $745,977
57,560 Added 128.55%
102,337 $1.24 Million
Q1 2019

May 15, 2019
BUY
$6.5 - $13.77 $123,324 - $261,258
18,973 Added 73.53%
44,777 $563,000
Q4 2018

Feb 14, 2019
SELL
$6.3 - $10.44 $64,927 - $107,594
-10,306 Reduced 28.54%
25,804 $174,000
Q3 2018

Nov 14, 2018
SELL
$6.82 - $11.26 $84,274 - $139,139
-12,357 Reduced 25.5%
36,110 $372,000
Q2 2018

Aug 14, 2018
BUY
$5.99 - $9.1 $191,296 - $290,617
31,936 Added 193.19%
48,467 $326,000
Q1 2018

May 15, 2018
BUY
$8.46 - $23.08 $139,852 - $381,535
16,531 New
16,531 $142,000

Others Institutions Holding PTGX

# of Institutions
212
Shares Held
59.1M
Call Options Held
19K
Put Options Held
107K
View Full List

About Protagonist Therapeutics, Inc

PTGX Quotes by TradingView
  • Ticker PTGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,084,100
  • Market Cap $2.34B
  • Description
  • Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...
More about PTGX
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email